Cytotoxic activity of vitamins K1, K2 and K3 against human oral tumor cell lines

被引:0
作者
Okayasu, H [1 ]
Ishihara, M
Satoh, K
Sakagami, H
机构
[1] Meikai Univ, Sch Dent, Dept Dent Pharmacol, Sakado, Saitama 3500283, Japan
[2] Meikai Univ, Sch Dent, Dept Chem, Sakado, Saitama 3500283, Japan
[3] Sch Pharmaceut Sci, Anal Ctr, Shinagawa Ku, Tokyo, Japan
关键词
vitamin K; cytotoxicity; DNA fragmentation; human oral tumor cells;
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Vitamin K-1, K-2 and K-3 were compared for their cytotoxic activity, radical generation and O-2(-) scavenging activity. Among these compounds, vitamin K-3 showed the highest cytotoxic activity against human oral tumor cell lines (HSC-2, HSG), human promyelocytic leukemic cell line (HL-60) and human gingival fibroblast (HGF). Vitamin K-3 induced internucleosomal DNA fragmentation in HL-60 cells, but not in HSC-2 or HSG cells. The cytotoxic activity of vitamins K-2 and K-1 was one and two orders lower, respectively, than K-3. Vitamin K-2, but not vitamin K-3 showed tumor-specific cytotoxic action. ESR spectroscopy showed that only vitamin K-3 produced radical(s) under alkaline condition and most potently enhanced the radical intensity of sodium ascorbate and scavenged O-2(-) (generated by hypoxanthine-xanthine oxidase reaction system); vitamin K-2 was much less active whereas vitamin K-1 was inactive. These data suggest that the cytotoxic activity of vitamin K-3 is generated by radical-mediated oxidation mechanism and that this vitamin has two opposing actions (that is, antioxidant and prooxidant), depending on the experimental conditions.
引用
收藏
页码:2387 / 2392
页数:6
相关论文
共 20 条
[1]  
Fujisawa S, 2000, IN VITRO MOL TOXICOL, V13, P269
[2]  
Fukai T, 2000, ANTICANCER RES, V20, P2525
[3]  
Gilloteaux J, 1998, SCANNING, V20, P564
[4]  
Ishihara M, 2000, ANTICANCER RES, V20, P4307
[5]   Flow cytometric and ultrastructural aspects of the synergistic antitumor activity of vitamin C - Vitamin K-3 combinations against human prostatic carcinoma cells [J].
Jamison, JM ;
Gilloteaux, J ;
Venugopal, M ;
Koch, JA ;
Sowick, C ;
Shah, R ;
Summers, JL .
TISSUE & CELL, 1996, 28 (06) :687-701
[6]  
Jiang Y, 2001, ANTICANCER RES, V21, P965
[7]  
Jiang Y, 2001, IN VIVO, V15, P145
[8]  
Kovalenko DV, 1999, BIOCHEMISTRY-MOSCOW+, V64, P468
[9]  
KUMADA T, 1996, BOICH BIOPHYS RES CO, V220, P515
[10]  
Sakagami H, 2000, ANTICANCER RES, V20, P271